Payer Almanac
About the data Sign in
Star measuresDisplay measuresHEDISWhy members leave

Measures · D08 in 2027 · Part D · DD4 Drug Safety and Accuracy of Drug Pricing

Medication Adherence for Diabetes Medications

Drug PlanMedication AdherenceSource: Prescription Drug Events

What it measures
The percentage of plan members with a prescription for diabetes medication who fill their prescription often enough to cover 80% or more of the time they are taking the medication. One of the most important ways people with diabetes can manage their health is by taking their medication. The plan, the doctor, and the member can work together to find ways to do this. (“Diabetes medication” means a biguanide drug, a sulfonylurea drug, a thiazolidinedione drug, a dipeptidyl peptidase 4 (DPP-4) inhibitor, a glucose-dependent insulinotropic polypeptide/glucagon-like peptide 1 (GIP/GLP-1) receptor agonist, a meglitinide drug, or a sodium glucose cotransporter 2 (SGLT2) inhibitor.)
How it's calculated
This measure is defined as the percentage of Medicare Part D beneficiaries, 18 years and older, who adhere to their prescribed drug therapy across classes of diabetes medications: biguanides, sulfonylureas, thiazolidinediones, DPP-4 inhibitors, GIP/GLP-1 receptor agonists, meglitinides, and SGLT2 inhibitors. The proportion of days covered (PDC) is the percentage of days in the treatment period “covered” by prescription claims for the same medication or another in its therapeutic category. The index prescription start date (IPSD) is the earliest date of service for a target medication during the measurement year. The treatment period begins on the IPSD and extends through whichever comes first: the last day of enrollment during the measurement year, death, or the end of the measurement year. The treatment period must be at least 91 days during the measurement year. Continuous enrollment (CE) is defined as being continuously enrolled in a Medicare Part D contract during the treatment period with no enrollment gaps allowed during the treatment period. This percentage is calculated as the number of continuously enrolled Medicare Part D beneficiaries, 18 years and older, with a PDC of 80 percent or higher across the classes of diabetes medications during the treatment period (numerator) divided by the number of continuously enrolled beneficiaries, 18 years and older, with at least two fills of diabetes medication(s) on unique dates of service during the treatment period, and a treatment period that is at least 91 days during the measurement year (denominator). The Medication Adherence measure is adapted from the Medication Adherence- Proportion of Days Covered measure that was developed and endorsed by the Pharmacy Quality Alliance (PQA). See the medication list for this measure. The Medication Adherence rate is calculated using the National Drug Code (NDC) list maintained by the PQA. The complete NDC list, including diagnosis codes, is posted along with these technical notes.
Data source
Prescription Drug Event (PDE) data The data for this measure come from PDE data submitted by drug plans to CMS Drug Data Processing Systems (DDPS) and accepted by the 2025 PDE submission deadline for annual Part D payment reconciliation with dates of service from January 1, 2025- December 31, 2025. If the PDE edit results in the PDE being rejected by DDPS, then the PDE is not used in the Patient Safety measure calculations. If the PDE edit is informational and therefore does not result in the PDE being rejected, then the PDE is used in the Patient Safety measure calculations. Reminder, CMS uses the term “final action” PDE to describe the most recently accepted original, adjustment, or deleted PDE record representing a single dispensing event. Original and adjustment final action PDEs submitted by the sponsor and accepted by DDPS prior to the 2025 PDE submission deadline are used to calculate this measure. PDE claims are limited to members who received at least two prescriptions on unique dates of service for diabetes medication(s). PDE adjustments made post-reconciliation are not reflected in this measure. Additional data sources include the Common Medicare Environment (CME), the Common Working File (CWF), and the Encounter Data Systems (EDS). The data cutoff date for all the additional data sources listed below such as the CME, CWF, and EDS is determined by the same PDE submission deadline for the annual Part D payment reconciliation. • CME is used for enrollment information and to identify beneficiaries who elected to receive hospice care or with ESRD status (dialysis start and end dates within the measurement period). • CWF is used to identify exclusion diagnoses based on ICD-10-CM codes (on inpatient, outpatient, or carrier claims), inpatient (IP) and skilled nursing facility (SNF) stays for PDPs and MA-PDs (if available). • EDS is used to identify exclusion diagnoses based on ICD-10-CM codes (on inpatient, outpatient, or carrier claims), and SNF/IP stays for MA-PD beneficiaries.
Measurement period
01/01/2025 – 12/31/2025
Better when
Higher
Weight
3 (Intermediate Outcome Measure)
Star assignment
Clustering
Case-mix adjusted
No
In improvement measure
Yes
Used in CAI
Yes
Exclusions
ShowContracts with 29 or fewer continuously enrolled beneficiaries (in the denominator). The following beneficiaries are also excluded from the denominator if at any time during the measurement period unless otherwise specified: • In hospice • ESRD diagnosis or dialysis coverage dates • One or more prescriptions for insulin in the treatment period
Notes
Part D drugs do not include drugs or classes of drugs, or their medical uses, which may be excluded from coverage or otherwise restricted under section 1927(d)(2) of the Act, except for smoking cessation agents. As such, these drugs, which may be included in the PQA medication or NDC lists, are excluded from CMS analyses. The PDC calculation is adjusted for overlapping prescriptions for the same drug, which is defined by the active ingredient at the generic name level using the NDC list maintained by PQA. The calculation also adjusts for Part D beneficiaries’ stays in IP settings and stays in SNFs. The discharge date is included as an adjustment for IP/SNF stays. Please see Attachment L: Medication Adherence Measure Calculations for more information about these calculation adjustments. When available, beneficiary death date from the CME is the end date of a beneficiary’s treatment period.
Disaster policy
Higher measure star (2026-2027) for contracts with 25% or more enrolled affected by 2025 disasters.

From the 2027 Star Ratings Technical Notes (CMS).

Cut points over time

Score needed to earn each star level. Part D thresholds differ for MA-PD and standalone PDP contracts. Dotted lines and open dots: where the cut points may move for 2028.

How the 2028 cut points are projected

Each boundary moves by its median year-on-year change since 2019, capped at 5 points, the most CMS lets a non-survey cut point move in a year. It's the same projection the Star outlook uses for every contract. CMS sets real cut points from all contracts' scores each year, so treat these as a direction, not a forecast of the exact number.

StarsOrg type2027Projected 2028Move
2★MA-PD8688+2
3★MA-PD8990+1
4★MA-PD9192+1
5★MA-PD9394+1
2★PDP86860
3★PDP88880
4★PDP90900
5★PDP95950

2027 star distribution

Not rated: Plan too new to be measured (94); Not enough data available (29); Plan not required to report measure (8)

Cut point bands

Star yearOrg type1★2★3★4★5★
2027MA-PD< 86 %>= 86 % to < 89 %>= 89 % to < 91 %>= 91 % to < 93 %>= 93 %
2027PDP< 86 %>= 86 % to < 88 %>= 88 % to < 90 %>= 90 % to < 95 %>= 95 %
2026MA-PD< 83 %>= 83 % to < 86 %>= 86 % to < 89 %>= 89 % to < 92 %>= 92 %
2026PDP< 85 %>= 85 % to < 87 %>= 87 % to < 89 %>= 89 % to < 92 %>= 92 %
2025MA-PD< 80 %>= 80 % to < 85 %>= 85 % to < 87 %>= 87 % to < 91 %>= 91 %
2025PDP< 85 %>= 85 % to < 87 %>= 87 % to < 89 %>= 89 % to < 93 %>= 93 %
2024MA-PD< 80 %>= 80 % to < 84 %>= 84 % to < 88 %>= 88 % to < 90 %>= 90 %
2024PDP< 84 %>= 84 % to < 87 %>= 87 % to < 89 %>= 89 % to < 93 %>= 93 %
2023MA-PD< 79 %>= 79 % to < 85 %>= 85 % to < 88 %>= 88 % to < 92 %>= 92 %
2023PDP< 84 %>= 84 % to < 86 %>= 86 % to < 88 %>= 88 % to < 90 %>= 90 %
2022MA-PD< 80 %>= 80 % to < 85 %>= 85 % to < 87 %>= 87 % to < 91 %>= 91 %
2022PDP< 84 %>= 84 % to < 86 %>= 86 % to < 88 %>= 88 % to < 90 %>= 90 %
2021MA-PD< 76 %>= 76 % to < 80 %>= 80 % to < 84 %>= 84 % to < 88 %>= 88 %
2021PDP< 79 %>= 79 % to < 82 %>= 82 % to < 85 %>= 85 % to < 87 %>= 87 %
2020MA-PD< 74%? 74% to < 78%? 78% to < 82%? 82% to < 85%? 85%
2020PDP< 79%? 79% to < 83%? 83% to < 85%? 85% to < 88%? 88%
2019MA-PD< 72%? 72% to < 78%? 78% to < 81%? 81% to < 85%? 85%
2019PDP< 82%? 82% to < 84%? 84% to < 86%? 86% to < 88%? 88%
2018MA-PD< 72%? 72% to < 78%? 78% to < 81%? 81% to < 86%? 86%
2018PDP< 76%? 76% to < 80%? 80% to < 84%? 84% to < 86%? 86%
2017MA-PD< 70%? 70% to < 76%? 76% to < 79%? 79% to < 83%? 83%
2017PDP< 74%? 74% to < 78%? 78% to < 82%? 82% to < 86%? 86%
2016MA-PD< 60%? 60% to < 69%? 69% to < 75%? 75% to < 82%? 82%
2016PDP< 75%? 75% to < 80%? 80% to < 83%? 83% to < 95%? 95%
2015MA-PD< 69%? 69% to < 73%? 73% to < 77%? 77% to < 81%? 81%
2015PDP< 74%? 74% to < 79%? 79% to < 82%? 82% to < 85%? 85%

Lowest-scoring contracts, 2027

ContractParentMembersScoreStarsΔShortfall to 4★Pctile
H8332 Aetna MedicareCVS Health Corporation197761−1150%
S0375 CareFirst BlueCross BlueShield Group Prescription Drug PlanCareFirst, Inc.549841—60%
H9066 Nascentia Health PlusVISITING NURSE ASSOCIATION OF CENTRAL NEW YORK6637610150%
H3551 eternalHealthEternal Health of Delaware, Inc.2,467771−1140%
H8879 Healthy Mississippi, Inc.Singh Holdings LLC500791—121%
H6959 KeyCare AdvantageISNP Holdings, LLC538801−2111%
H0738 AmeriHealth Caritas VIP Care (HMO-D-SNP)Independence Health Group, Inc.1,048801—111%
H2185 Lifeworks AdvantageCurana Health Holdings, LLC314801−1111%
H3928 Aetna MedicareCVS Health Corporation4,9128110101%
H4676 Troy MedicareTroy Holdings, Inc.1,6548110101%
H0270 WellcareCentene Corporation631811−2101%
H2926 PrimeWest HealthPrimeWest Rural MN Health Care Access Initiative749811−2101%
H1947 Healthy BlueElevance Health, Inc.3,486821−192%
H4490 American Health Advantage of MissouriMitchell Family Office832821−192%
H9460 HealthSpringHealth Care Service Corporation1,325821092%
H3814 ATRIO Health PlansATRIO Health Plans1,997821092%
H9431 Aetna MedicareCVS Health Corporation666821−292%
S5966 EmblemHealthEmblemHealth, Inc.105,012851052%
S5795 Arkansas Blue MedicareUSAble Mutual Insurance Company19,195851−152%
H9147 Blue Cross and Blue Shield of North CarolinaCuraCor Solutions Corp.3,516831−283%
H0074 WellcareCentene Corporation1,451831−283%
H3407 El Paso Health Medicare AdvantageEl Paso County Hospital District2,178831−183%
H5435 UnitedHealthcareUnitedHealth Group, Inc.1,420831−183%
H6345 PruittHealth PremierUNICO Services, Inc.882831−283%
H5475 WellcareCentene Corporation18,951831083%

History

Star yearCodeNameMeasuredWeightSource
2027D08Medication Adherence for Diabetes Medications01/01/2025 – 12/31/20253Prescription Drug Events
2026D08Medication Adherence for Diabetes Medications01/01/2024 – 12/31/20243Prescription Drug Events
2025D08Medication Adherence for Diabetes Medications01/01/2023 – 12/31/20233Prescription Drug Events
2024D08Medication Adherence for Diabetes Medications01/01/2022 – 12/31/20223Prescription Drug Events
2023D08Medication Adherence for Diabetes Medications01/01/2021 – 12/31/20213Prescription Drug Events
2022D08Medication Adherence for Diabetes Medications01/01/2020 – 12/31/20203Prescription Drug Events
2021D10Medication Adherence for Diabetes Medications01/01/2019 – 12/31/20193Prescription Drug Events
2020D10Medication Adherence for Diabetes Medications01/01/2018 – 12/31/2018—Prescription Drug Events
2019D10Medication Adherence for Diabetes Medications01/01/2017 – 12/31/20173Prescription Drug Events
2018D11Medication Adherence for Diabetes Medications01/01/2016 – 12/31/20163Prescription Drug Events
2017D12Medication Adherence for Diabetes Medications01/01/2015 - 12/31/20153Prescription Drug Events
2016D12Medication Adherence for Diabetes Medications01/01/2014 - 12/31/20143Prescription Drug Events
2015D11Medication Adherence for Diabetes Medications01/01/2013 - 12/31/20133Prescription Drug Events